World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

FACTOR ASSOCIATE WITH MORTALITY RATE AFTER BALLOON AORTIC VALVULOPLASTY INOPERABLE PATIENTS WITH SEVERE AORTIC STENOSIS WITHOUT SUPPORT OF TRANSCATHETER AORTIC VALVULAR IMPLEMENTATION

Jovica Banovic*, Sasa Loncar, Jelena Banovic Fuentes and Maja Amidzic

ABSTRACT

Aim/objectives: Aortic balloon valvuloplasty (BAV) is a therapeutic option for some patients who are at high risk of transcatheter aortic replacement or surgical valve replacement and have severe aortic stenosis. In our research we examined survival and prognostic predictors in patients undergoing BAV with severe aortic stenosis. Methods: The study was conducted at the University Clinical Center of the Republic of Srpska. Patients diagnosed with severe aortic stenosis with high-risk for surgical replacement of the aortic valve, on which are preformed BAV procedure, after the decision made by the council of interventional cardiologists, were consider eligible candidate. Results: Patients (n=23) undergoing BAV procedure are elderly (mean age 80.9 years; minimum age 67 and maximum 92). There were 15 women (65.2%), and 8 men (34.8%). Total mortality after 1, 6 and 12 months was retrospectively 17%/27%/45%. The average survival was 14.1 months. The statistically significant predictors for one month survival were NYHA class and urgency of procedure. Hemodynamic parameters became better after the procedure, with statistically significant drop comparing to same parameters before procedure. Conclusion: Balloon aortic valvuloplasty is a relatively simple procedure, and the modern approach to it is as a rescue procedure and to give a window for patients to have better hemodynamic parameters and clinicians to prepare itself and patient for TAVR procedure.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR